Tandem Diabetes Care, Inc. (TNDM) is a publicly traded Healthcare sector company. As of July 28, 2026, TNDM trades at $17.76 with a market cap of $1.17B and a P/E ratio of -11.86. TNDM moved +4.40% today. Year to date, TNDM is -21.88%; over the trailing twelve months it is +8.06%. Its 52-week range spans $9.98 to $38.28. Analyst consensus is buy with an average price target of $28.89. Rallies surfaces TNDM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TNDM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $17.76 |
| Market Cap | $1.17B |
| P/E Ratio | -11.86 |
| EPS | $-1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $38.28 |
| 52-Week Low | $9.98 |
| Volume | 639.26K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.03B |
| Net Income | $-94.55M |
| Gross Margin | 54.93% |
15 analysts cover TNDM: 0 strong buy, 9 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.89.